⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22220176 | 1.00 | — | — | |
| SCHEMBL22208147 | 0.79 | — | — | |
| SCHEMBL22220380 | 0.76 | — | — | |
| SCHEMBL29634811 | 0.76 | — | — | |
| SCHEMBL31552293 | 0.76 | — | — | |
| SCHEMBL22208171 | 0.76 | PDE5A (0.33) | — | |
| SCHEMBL11654423 | 0.72 | GPR35 (0.33) | — | |
| SCHEMBL8139070 | 0.72 | DHODH (0.39) | — | |
| SCHEMBL27100901 | 0.72 | — | — | |
| SCHEMBL22555063 | 0.72 | GPR35 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4598921-A1 | MACROCYCLIC KRAS INHIBITORS AND METHODS OF USE | Amgen Inc. (US) | 2025-08-13 | — | — | EP | disclosed |
| US-20240417412-A1 | HETEROCYCLIC COMPOUNDS AND METHODS OF USE | AMGEN INC. (US) | 2024-12-19 | — | — | US | disclosed |
| WO-2024107686-A1 | MACROCYCLIC KRAS INHIBITORS AND METHODS OF USE | AMGEN INC. (US) | 2024-05-23 | — | — | WO | disclosed |